LifeStance Health Group, Inc. LFST
Nov 6, 2026, 3:10 PM EST
- YTD
- +96.57%
- 1 year
- +121.42%
- Market cap
- 5.25B
- Revenue (ttm)
- 1.58B
- Profit margin
- 3.19%
- EPS (ttm)
- 0.18
- Shares out
- 380.15M
- P/E ratio
- 76.78
- Forward P/E
- 32.99
- YTD return
- +96.57%
- 1-year return
- +121.42%
- Volume
- 2.65M
- Avg volume
- 4.42M
- Open
- 13.60
- Previous close
- 13.43
- Day's range
- 13.45 – 14.07
- 52-week range
- 5.87 – 15.66
- Beta
- 1.30
- Analysts
- Buy
- Price target
- 14.45 (+4.4%)
- Earnings date
- Feb 24, 2027
5D +0.39 (+2.90%)
Key statistics
- Enterprise value
- 5.36B
- PEG ratio
- 0.00
- Price / sales
- 3.41
- Price / book
- 3.67
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 26.10%
- Free cash flow
- 172.36M
- Total cash
- 225.94M
- Total debt
- 474.15M
- Return on equity
- 3.43%
- Short % of float
- 7.54%
- 50-day average
- 12.52
- 200-day average
- 9.40
Analyst view
Consensus: buy
- Target (low)
- 12.00
- Target (mean)
- 14.45
- Target (high)
- 18.00
- Strong buy2
- Buy7
- Hold2
- Sell0
- Strong sell0
Next earnings
Feb 24, 2027
Expected Feb 24, 2027. Consensus EPS estimate 0.08388.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 24, 2027 | Dec 30, 2026 | 0.03 | — | — | — |
| Nov 5, 2026 | Sep 30, 2026 | 0.03687 | 0.06 | +0.02 | +62.73% |
| Aug 6, 2026 | Jun 30, 2026 | 0.03275 | 0.06 | +0.03 | +83.21% |
| May 7, 2026 | Mar 31, 2026 | 0.01 | 0.04 | +0.03 | +300.00% |
| Feb 25, 2026 | Dec 31, 2025 | -0.00094 | 0.03 | +0.03 | +3,291.49% |
| Nov 6, 2025 | Sep 30, 2025 | -0.01 | 0.00277 | +0.01 | +127.70% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | Keybanc | main | Overweight | Overweight |
| Sep 10, 2026 | Barclays | main | Overweight | Overweight |
| Sep 9, 2026 | Canaccord Genuity | main | Buy | Buy |
| Aug 19, 2026 | BTIG | main | Buy | Buy |
| Aug 14, 2026 | JP Morgan | main | Neutral | Neutral |
| Aug 7, 2026 | BTIG | main | Buy | Buy |
About LifeStance Health Group, Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- lifestance.com
News
Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $16 
Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $17 
What LifeStance Health Group (LFST) Said on Its Q3 Earnings Call 
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $20 
LifeStance Health Gr Q3 2026 Earnings Call Transcript 
LifeStance Health Group (LFST) Tops Q3 Earnings and Revenue Estimates - LifeStance Health Gr Sees Q4 Sales $446.000M-$466.000M vs $438.561M Est
LifeStance Health Gr Raises FY2026 Sales Guidance from $1.685B-$1.725B to $1.741B-$1.761B vs $1.709B Est 
LifeStance Health Gr Q3 EPS $0.06 Beats $0.04 Estimate, Sales $455.900M Beat $431.816M Estimate 
LifeStance Reports Strong Third Quarter 2026 Financial Results and Raises Full Year Outlook
Your note
Sign in to keep a note on LFST — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BESSLER ROBERT | Director | Stock Award(Grant) | Jul 1, 2026 | 1,308,050 |
| BLACK DARREN M | Director | Sale | May 11, 2026 | 0 |
| BOURDON DAVID | Chief Executive Officer | Stock Award(Grant) | Mar 8, 2026 | 1,398,250 |
| BURDICK KENNETH A | Director | Sale | Aug 10, 2026 | 3,017,320 |
| PANTALEONI PABLO | Officer | Sale | Mar 9, 2025 | 0 |
| PARDO RYAN | Officer and Director | Stock Award(Grant) | Mar 8, 2026 | 3,654,260 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| TPG GP A, LLC | 29.24% | 111,744,614 | 1.59B | Jun 29, 2026 |
| FMR, LLC | 15.24% | 58,252,466 | 827.77M | Jun 29, 2026 |
| Blackrock Inc. | 9.51% | 36,348,507 | 516.51M | Jun 29, 2026 |
| Summit Partners, L.P. | 4.35% | 16,623,824 | 236.22M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 3.65% | 13,960,892 | 198.38M | Jun 29, 2026 |
| Jennison Associates LLC | 3.16% | 12,077,557 | 171.62M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 4.21% | 16,071,660 | 228.38M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.76% | 6,740,311 | 95.78M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.69% | 6,465,187 | 91.87M | Sep 29, 2026 |
| Variable Insurance Products Fund II-VIP Contrafund Portfolio | 1.55% | 5,911,337 | 84.00M | Aug 30, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 1.42% | 5,442,419 | 77.34M | Jul 30, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.31% | 4,997,380 | 71.01M | Aug 30, 2026 |